Showing of 8 results
Physician Highlight: Tiffany Hodges, MD
Mentoring the next generation – Innovations in Neurology & Neurosurgery | Summer 2021
Novel Gene Therapy Treatment for Glioblastoma Moves Forward at UH Seidman Cancer Center
Phase II clinical trial of promising approach soon to begin at UH Seidman and second site at the NIH Clinical Center - Innovations in Cancer | Winter 2021
Physician Spotlight: Andrew E. Sloan, MD
Neurosurgeon advances brain cancer research, surgical techniques - Innovations in Neurology & Neurosurgery | Winter 2020
Can the Polio Virus Kill Brain Tumors?
UH one of 4 sites participating in Phase II clinical trial - Innovations in Neurology & Neurosurgery | Winter 2020
UH Neurosurgeon Testing Novel Gene Therapy Treatment for Glioblastoma
New $2.7 million grant from the National Cancer Institute will help validate promising approach - Innovations in Cancer | Summer 2019
Newly FDA-approved Imaging Agent That Makes Brain Tumors Glow Hot Pink
Distinguishes tumor from healthy tissue to improve tumor removal The imaging agent 5-Aminolevulinic Acid (5-ALA), which helps neurosurgeons see the edges of a tumor more clearly to improve removal, was used in brain cancer surgery at University...
Nature Medicine Study Areas of Glioblastoma Tumors
Andrew Sloan, MD, of University Hospitals Cleveland Medical Center, senior co-author of new report Andrew Sloan, MD, FACS A new study published in the Oct. 9 issue of the journal Nature Medicine demonstrates, for the first time, that...
Gene Therapy and Glioblastoma
Innovations in Cancer | Winter 2017